Dr. Nagalapuram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 NE 10th St
# Okcc
Oklahoma City, OK 73104Phone+1 405-271-4022Fax+1 334-284-9020
Education & Training
- University of Alabama Medical Center (Montgomery)Residency, Internal Medicine, 2019 - 2022
- PSG Institute of Medical SciencesClass of 2018
Certifications & Licensure
- OK State Medical License 2022 - 2025
- AL State Medical License 2020 - 2022
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Immune tolerance induction for inhibitor eradication in nonsevere hemophilia A: a case series.Sanober Nusrat, Niveditha Popuri, Vishnu Nagalapuram, Osman Khan
Research and Practice in Thrombosis and Haemostasis. 2025-01-01 - Osimertinib for Uncommon Endothelial Growth Factor Receptor-Mutant Non-Small Cell Lung Carcinoma: A Case Report.Niveditha Popuri, Vishnu Nagalapuram, Unaiza Zaman, Raid Aljumaily
Case Reports in Oncology. 2024-11-21 - 1 citationsMulti-organ dysfunction secondary to abrupt discontinuation of voxelotor in a patient with severe sickle cell disease.Vishnu Nagalapuram, Julie Kanter
American Journal of Hematology. 2022-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: